-
Ketamine May Relieve Depression By Repairing Damaged Brain Circuits
Ketamine appears to restore faulty connections between brain cells, according to research performed in mice. The anesthetic ketamine can relieve depression in hours and keep it at bay for a week or more. Now scientists have found hints about how ketamine works in the brain. In mice, the drug appears to quickly improve the functioning…
-
Weekly Ketamine Infusions Show Initial, Repeated Depression Benefits
A new study shows that weekly ketamine infusions are associated with continued and maintained reductions in depressive symptoms among patients with treatment-resistant depression. The findings, which are considered novel among studies assessing ketamine administration for patients with treatment-resistant depression, evidence the promising role the controversial drug could play in psychiatric care. A team of investigators, led…
-
RESILIENCE! It’s the New Buzzword Among People with Mood and Anxiety Disorders
Too much screen time? Let yourself have 2 more minutes of it right now: because if you’ve been tooling around reading anything related to mood disorders or anxiety disorders, IV ketamine, and other advanced treatments, you’ve probably noticed that there’s buzz about resilience. Because of the world that has opened up since IV ketamine began…
-
PTSD in Trauma Survivors: Let’s Prevent More Suicide
Two survivors of the Parkland high school shooting on Valentine’s Day 2018 took their own lives a couple weeks ago. Sydney Aiello, a senior and cheerleader at Marjory Stoneman Douglas High School, struggled to restore normalcy in her life after the terrifying experience. Her trauma, of course, included the loss of friends who were killed…
-
Misinformation about Esketamine (Spravato) and IV Ketamine
They’re different, but each can bring relief to those who suffer. As word gets out that esketamine intranasal spray has been approved by the FDA, the internet is rippling with articles, posts, interviews, newsclips and press releases about ketamine — IV ketamine, esketamine, and ketamine nasal spray. And — online forums and meeting places are…
-
Ketamine: Dissociation Quality Determines Remission
Transformative remission is inextricably linked to the quality, depth, and degree of dissociation during ketamine infusions. Christopher trudged through the day, listless. He felt dead inside. Just couldn’t work up a care about what happened at the job interview. But practicality — the bills were piling up — drove him to go anyway. He did…
-
The FDA accepted a brand new ketamine melancholy drug — right here’s what’s subsequent
For years, ketamine clinics across the country have offered intravenous infusions as a fast-acting treatment for severe depression. But last week, the US Food and Drug Administration approved a version of ketamine, called esketamine, to do the same thing — so what’s the difference and what will this mean for newly interested patients? Ketamine, sometimes…
-
The FDA approved a new ketamine depression drug — here’s what’s next
The newly approved drug, esketamine, is one half of the ketamine compound. By Angela Chen@chengela Mar 11, 2019, 3:45pm EDTIllustration by Alex Castro/The Verge For years, ketamine clinics across the country have offered intravenous infusions as a fast-acting treatment for severe depression. But last week, the US Food and Drug Administration approved a version of ketamine, called esketamine,…
-
Esketamine FDA Approval Marks a New Era in Psychiatric Medicine
Have you heard? In the “ketamine for depression” world we’re all a-buzz. Esketamine nasal spray’s been added to our arsenal to fight refractory depression. This is the first psychiatric medicine of its kind to win FDA approval. A medicine developed in a new brand new direction — glutamate modulation — to stimulate production of BDNF…